Xiaoyuan Xu

机构：Shanghai Jiao Tong University, Peking University, Shanghai Advanced Research Institute, Peking University First Hospital · ORCID：0000-0002-1759-4330

发表论文 219 篇 · 总被引 2421 次 · h-index 24

代表论文

• Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024) (2024 · Journal of Clinical and Translational Hepatology · 被引 72)
• Interobserver consistency and diagnostic challenges in HER2-ultralow breast cancer: a multicenter study (2025 · ESMO Open · 被引 28)
• Greenwashing in ESG information disclosure: An intertemporal signaling game approach (2025 · International Journal of Production Economics · 被引 13)
• Overexpression of the Transcription Factor GmbZIP60 Increases Salt and Drought Tolerance in Soybean (Glycine max) (2025 · International Journal of Molecular Sciences · 被引 10)
• Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024) (2025 · Journal of Clinical and Translational Hepatology · 被引 7)
• Signaling cost to distributive fairness sensitive customers with price guarantee window (2025 · Journal of Retailing and Consumer Services · 被引 4)